News and Reports

Globe
  • Monte Rosa Therapeutics Provides Development Progress Updates on MRT-2359 and MRT-6160

    27 June 2024
    Download
  • Transaktion HBM-Portfoliounternehmen Yellow Jersey geht an Johnson & Johnson

    28 May 2024
    Download
  • Numab Therapeutics Announces Johnson & Johnson to Acquire its Wholly-owned Subsidiary Yellow Jersey Therapeutics Including Rights to NM26, a Bi-specific Antibody for the Treatment of Atopic Dermatitis

    28 May 2024
    Download
  • Swixx BioPharma Expands to Latin America Through a Strategic Acquisition and Combination with Biopas

    22 May 2024
    Download
  • Bluejay Therapeutics Secures $182 Million in Series C Financing to Propel Clinical Pipeline

    9 May 2024
    Download
  • Karius Raises $100M Co-Led by Khosla Ventures, 5AM Ventures and Gilde Healthcare, to Expand Access to Advanced Genomic Diagnostics in Infectious Disease, Addressing Antimicrobial Resistance Crisis

    2 May 2024
    Download
  • NiKang Therapeutics Doses First Patient in a Phase 1/1b Study of NKT3447, an Oral, Selective Inhibitor of CDK2 Which Reduces Cyclin E Expression

    15 April 2024
    Download
  • eGenesis Announces World’s First Successful Transplant of Genetically Engineered Porcine Kidney in a Living Patient

    21 March 2024
    Download
  • Upstream Bio Initiates a Phase 2 Clinical Trial of Verekitug (UPB-101) in Severe Asthma and Doses First Patients

    7 March 2024
    Download
  • Alumis Announces Upsized $259M Series C Financing to Advance Clinical-stage Pipeline of Oral Therapies Designed to Address Immune Dysfunction

    6 March 2024
    Download
  • Shape Memory Medical Completes $38 Million in Financing to Advance Endovascular Embolization

    4 March 2024
    Download
  • FogPharma Announces $145 Million Financing to Support Ongoing Clinical Development of FOG-001 and Accelerate Helicon Peptide Portfolio

    1 March 2024
    Download
  • Freenome Raises $254 Million in New Funding to Accelerate its Platform for Early Cancer Detection

    15 February 2024
    Download
  • Numab Therapeutics and Ono Pharmaceutical Announce an Option and Collaboration Agreement to Develop Multi-specific Antibody NM49 for Treatment of Cancer

    14 February 2024
    Download
  • Encoded Therapeutics Announces US IND Clearance and Australian CTA Approval for Dravet Syndrome Gene Therapy Candidate ETX10

    6 February 2024
    Download
  • Cathay Biotech Inc. and 3P.COM Co. Limited Signed Joint Venture Agreement to Propel Thermoplastic Bio-Based Polyamide Composites Innovation

    2 February 2024
    Download
  • Cathay Biotech’s Progress Report in Bio-based High Temperature Polyamides (PPA) and Composite Technologies

    2 February 2024
    Download
  • ArriVent Announces Pricing of Upsized Initial Public Offering

    25 January 2024
    Download
  • eGenesis and OrganOx Announce Successful Use of a Genetically Engineered Porcine Liver with a Human Donor

    19 January 2024
    Download
  • Upstream Bio Announces Dosing of First Patients in a Phase 2 Clinical Trial of Verekitug (UPB-101) in Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)

    3 January 2024
    Download
  • Shape Memory Medical Announces Sublicense of Intellectual Property

    11 December 2023
    Download
  • Synthetic Biology’s Great Attack - Dr. Xiucai Liu, Chairman of Cathay Biotech, discussing the status and future of the synthetic biology industry

    30 November 2023
    Download
  • Dren Bio Strengthens Leadership Team with Appointment of Amit Mehta, Ph.D., as Chief Operating Officer and Chief Business Officer

    30 October 2023
    Download
  • Upstream Bio Announces Positive Phase 1b Interim Data in Asthma and Company Progress Toward Phase 2

    24 October 2023
    Download
  • Numab Therapeutics Announces First Patient Dosed in Phase 1 Multiple Ascending Dose (MAD) Study of NM26 for Moderate to Severe Atopic Dermatitis

    19 October 2023
    Download